Danish drugmaker Novo Nordisk has partnered Emcure Pharmaceuticals to commercialise Poviztra, a 2.4 milligram (mg) ...

Novo Nordisk partners with Emcure to promote Wegovy, following Eli Lilly's recent collaboration with Cipla for tirzepatide in ...

The partnership comes just five months after Wegovy debuted in India, and signals Novo Nordisk’s intent to scale access ...

After a few months on fat jabs such as Wegovy or Mounjaro, the feeling of suppression can start to wane and weight loss can ...

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...

The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it ...

Our Bureau, Mumbai Monday, November 10, 2025, 12:45 Hrs [IST] ...

Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra, the second brand of Wegovy.

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...

Novo Nordisk India has joined forces with Emcure Pharmaceuticals to commercialize Poviztra, a weight-loss drug, in an effort ...

According to Pharmarack, unlike the previous two years where October sales for Oral Rehydration Solutions (ORS) is lesser ...

The collaboration gives Emcure exclusive rights to distribute and commercialise semaglutide for chronic weight management in India.